Severe constipation associated with the use of rufinamide (Banzel) in an adolescent

Epilepsy and Behavior

Volumn 18, Issue 1-2, 2010, Pages 132-

  Drake, Kendra ^a   Labiner, David M ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREGABALIN; RUFINAMIDE; TOPIRAMATE; ANTICONVULSIVE AGENT; TRIAZOLE DERIVATIVE;

ADOLESCENT; ATAXIA; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; LETHARGY; LETTER; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE; VAGUS NERVE STIMULATION; WEIGHT REDUCTION; CHEMICALLY INDUCED; EPILEPSIES, PARTIAL;

ADOLESCENT; ANTICONVULSANTS; CONSTIPATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; TRIAZOLES;

EID: 77953913639     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.03.001     Document Type: Letter

References (5)

1. Arroyo S. Rufinamide. Neurotherapeutics 2007, 4:155-162.
2. Brodie M.J., Rosenfeld W.E., Vazquez B., et al. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Epilepsia 2009, 50:1899-1909.
3. Kluger G., Kurlemann G., Haberlandt E., et al. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience. Epilepsy Behav 2009, 14:491-495.
4. Glauser T., Kluger G., Sachdeo R., Krauss G., Perdomo C., Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008, 70:1950-1958.
5. Wheless J.W., Conry J., Krauss G., Mann A., LoPresti A., Narurkar M. Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies. J Child Neurol 2009, 24:1520-1525.